NovoCure Ltd. (NVCR) PT Raised to $31 at Deutsche Bank

April 27, 2018 7:46 AM

Deutsche Bank raised its price target on NovoCure Ltd. (NASDAQ: NVCR) to $31.00 (from $29.00) while maintaining a Buy rating.Analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found